PTC Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
Okay. Welcome, everyone. We'll continue with the next session. My name is Paul Choi, and I cover the small and mid-cap biotechnology sector here at Goldman Sachs. It's my pleasure to welcome the management team from PTC. To my immediate right, we have Dr. Matt Klein. And at the far end there, we have Kylie O'Keefe.
What we'll do is the usual format. Maybe I'll let Matt kick it off with a couple of high-level comments, and then we'll go into Q&A. If anybody in the audience has questions along the way, please feel free to raise your hand, and we'll get a mic to you. Also, for those who are listening on the webcast, if you have any questions, please e-mail them to us, and we'll read them anonymously if time allows.
But otherwise, with that, I'll let Matt kick it off here.
Great. Thanks so much, Paul. It's great to be here today. For those of you who don't know PTC, we are a global biopharmaceutical company
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
